INDV · Mid Cap · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Free AI brief
Free to track. No card required. Usually ready in 10-15 minutes.
Price, momentum, and the numbers behind the story.
Stocksbrew score
78/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Current price
$36.04
Lowest
$43
Median target
$50
Highest
$53
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Forward P/E
Favorable · 43% below avg
7.74x
EV / EBITDA
Strong · Earnings support price
7.84x
ROIC
Strong · Excellent capital returns
130.9%
Current ratio
Weak · Low cash for bills
0.84x
INDV against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $4.23B | 12.7 | +13.5% | 78 | |
| $10.02B | 19.1 | +19.7% | 78 | |
| $31.74B | 33.2 | +15.5% | 78 | |
| $1.11T | 40.1 | +49.6% | 77 | |
| $61.93B | 17.3 | +13.5% | 73 |
Every story that touched the stock this week, newest first.